🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 23 (from laksa168)

2. Crawled Status Check

Query:

curl -X POST \
  'http://laksa023.int.ahrefs:8124/' \
  -H 'Content-Type: text/plain' \
  -H 'X-ClickHouse-Database: crawler3' \
  -H 'Authorization: Basic YXBpOg==' \
  -d 'SELECT getAhrefsURLFromUnparsed(src_unparsed) AS found_url, ifNull(toUnixTimestamp(download_stamp), 0) AS crawl_time, ifNull(toUnixTimestamp(props_url_first_seen), 0) AS first_indexed_time, download_http_code AS http_code, src_unparsed AS src_unparsed, src_root_hash AS src_root_hash, history_drop_reason AS history_drop_reason, meta_title AS meta_title, meta_descriptions AS meta_descriptions, attrs_boilerpipe_text AS attrs_boilerpipe_text, attrs_markdown AS attrs_markdown, attrs_readable_markdown AS attrs_readable_markdown, meta_canonical AS meta_canonical FROM crawler3.page_info_local FINAL PREWHERE (src_root_hash, src_unparsed) IN ((getAhrefsRootHashFromUnparsed(getAhrefsUnparsedNoserviceFromURL(\'https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments\')), getAhrefsUnparsedNoserviceFromURL(\'https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments\'))) FORMAT JSONEachRow'

Response:

{"found_url":"https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments","crawl_time":1768622534,"first_indexed_time":1634227224,"http_code":200,"src_unparsed":"org,science!www,\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments s443","src_root_hash":"18350995765413815023","history_drop_reason":null,"meta_title":"COVID-19 ‘brain fog' inspires search for causes and treatments | Science | AAAS","meta_descriptions":[],"attrs_boilerpipe_text":"Science\n's COVID-19 reporting is supported by the Heising-Simons Foundation.\nSince she fell ill with COVID-19 around Thanksgiving, Pamela Furr has been waiting for her old self to return. A radio news anchor in Tennessee for more than 10 years, she now sometimes finds herself stuck midsentence grasping for simple words; she is prone to forget events and conversations if she doesn't write them down. \"I'm not the same person that I was before COVID,\" she says. \"I kind of miss me.\"\nThe true prevalence of cognitive problems in COVID-19 survivors is elusive, and the underlying causes of lingering symptoms\nare the subject of ongoing studies\n. But it's now clear that trouble thinking, concentrating, and remembering can be among the most debilitating \"long-haul\" symptoms and can persist for months. As more and more people seek help to overcome their brain fog at clinics set up for post–COVID-19 care, researchers and physicians are turning to treatments developed for stroke and traumatic brain injuries. And a few are setting out to test cognitive training video games they hope will expand the reach of therapy.\n\"Even if it's a fairly small percentage [of survivors] who report cognitive problems, the number of overall people in that category … represents a tremendous problem,\" says James Jackson, a clinical psychologist at the Vanderbilt University School of Medicine's ICU Recovery Center, where Furr will participate in a support group for COVID-19 long haulers.\nCognitive impairment is common after serious illness. It's among the symptoms of a condition called\npost–intensive care syndrome\nthat can follow the isolation, immobility, and sedation of a hospital stay. And severe COVID-19 can itself damage the brain during its acute phase. SARS-CoV-2 may rarely invade brain tissue directly; most neurological damage is thought to stem from the indirect effects of infection, such as inflammation, stroke, and lack of oxygen.\n\"I'm not sure that what we're seeing post-COVID is different\" from impairments after other serious respiratory illnesses, says Faith Gunning, a neuropsychologist at Weill Cornell Medicine (WCM). She and colleagues reported in February that of 57 recovering COVID-19 patients referred for neuropsychological evaluation before hospital discharge,\n81% had cognitive impairment\n. Most experienced problems with attention and executive function, which includes skills like planning, organization, and multitasking.\nAnd such symptoms aren't limited to people who wound up hospitalized. The majority of people visiting post–COVID-19 outpatient clinics had a relatively mild acute phase of illness, says Igor Koralnik, a neurologist at Northwestern University's Feinberg School of Medicine. He oversees the Neuro COVID-19 Clinic at Northwestern Memorial Hospital, which has seen more than 400 patients since it opened in May 2020. Among the first 100 patients with confirmed COVID-19 infections whose symptoms lasted at least 6 weeks,\n81 experienced \"brain fog,\"\nthe most common neurologic symptom, Koralnik's team reported last month in the\nAnnals of Clinical and Translational Neurology\n.\nAfter brain injury, cognitive rehab typically involves testing to identify cognitive weaknesses and training to help patients navigate daily life. Often, the focus is on compensating for deficits, not eliminating them outright. Jackson's team at Vanderbilt recommends a rehabilitation program called goal management training, originally developed to manage impairments after stroke, traumatic brain injury, or age-related decline. It trains patients in \"metacognitive skills\" such as observing their own thought processes, identifying situations where they're prone to make cognitive errors, and reflecting on how to approach a new task.\nIt can be \"a game changer\" for patients, Jackson says. He expects such training to benefit people with post–COVID-19 impairments—but only if their primary care physicians refer them as they would people who had a stroke or traumatic injury. For now, that happens rarely, he says.\nAny time you're developing a treatment, you need to understand the mechanism. But we can't afford to wait. We need to do something now.\nAna-Maria Vranceanu, Harvard Medical School\nComplicating matters for doctors is that the nature of the injuries is often far from clear. \"We don't really know what happened to them,\" says Serena Spudich, an infectious disease neurologist at the Yale School of Medicine. When cognitive dysfunction appears after mild COVID-19, it raises the possibility that an immune response that was protective in the acute phase has become overactive and triggered continuing inflammation, she says. Spudich leads a study using brain imaging along with analyses of spinal fluid and other biological samples to look for signs of inflammation and other abnormalities in patients with persistent post–COVID-19 neurological symptoms.\nThere are other possible explanations for cognitive impairments. \"Things like sleep and exhaustion, pain and stress and depression—all of these nonneurological issues also play a role in our cognitive functioning,\" says Renee Madathil, a rehabilitation neuropsychologist at the University of Rochester Medical Center. Cognitive impairments rooted in depression or stress aren't any less \"real\" than those caused by direct injury to the brain, Madathil and others stress. But different causes may call for different therapies.\n\"Any time you're developing a treatment, you need to understand the mechanism,\" says Ana-Maria Vranceanu, a clinical health psychologist at Harvard Medical School. \"But we can't afford to wait,\" she adds. \"We need to do something now.\" In prepandemic studies of intensive care unit (ICU) survivors, her team found that elevated emotional distress spelled a slower recovery. Her team developed a training program to help ICU survivors and their families manage distress, anxiety, and depression, which she aims to adapt for COVID-19 recovery.\nTo help people who neither live near rehabilitation centers nor have access to specialists, a few researchers are exploring a newer category of potential treatments: cognitive training through video games played at home.\nIn response to what he calls \"a tsunami of patients with Long COVID,\" Radboud University Medical Center professor of surgery Harry van Goor, with Radboud physical therapy researcher Bart Staal, is testing a virtual reality platform and a set of games that involve physical activity, cognitive skills, and mindfulness. A pilot study in 48 people recovering from COVID-19 suggests the puzzlelike cognitive games were highly motivating, the researchers say; they next hope to launch a controlled trial of the approach versus traditional rehab.\nMeanwhile, Jackson's team at Vanderbilt and Gunning's at WCM are gearing up to test a \"digital treatment\" developed by Akili Interactive, which last year became the first company to win approval from the U.S. Food and Drug Administration for a video game as a prescription therapy.\nThe technology, so far approved for attention deficit hyperactivity disorder (ADHD), \"is not just a blunderbuss approach\" to treat any condition that involves cognitive dysfunction, says Anil Jina, Akili's chief medical officer. Instead, it's designed to improve attention—for example, by having players multitask to collect items in the game while avoiding obstacles. A study of more than 300 children with ADHD published last year showed that those who played the game\nshowed greater improvements\nin computerized attention tests and on parent and clinician assessments than those who used an educational video game.\nA video game developed by Akili Interactive challenges attention with a series of targets and obstacles.\nAkili Interactive\nGunning's study, set to launch next month, aims to include 100 participants who have lingering cognitive deficits after COVID-19; Jackson's group expects to include more than 50 people with such symptoms. In both studies, half the participants will be assigned to 6 weeks of at-home play. Half will serve as controls but will have access to the game after the assessment is complete.\nThe brain-training industry\nhas a checkered reputation\nwhen it comes to science. In 2016, Lumos Labs, the company behind the popular program Lumosity, agreed to pay the Federal Trade Commission $2 million to settle false advertising charges after promoting its games as a way to stave off Alzheimer's disease and other conditions without adequate evidence.\nIn studies of cognitive decline accompanying aging, puzzles and cognitive games haven't proved as effective as physical activity and an active social life, Vranceanu notes. \"If you're doing Sudoku, you're getting good at Sudoku,\" she says, \"but that doesn't necessarily translate to you getting better at not misplacing your keys.\"\nAnd in rehabilitation, the transfer of skills from games and exercises in the clinic to everyday life \"does not occur easily,\" cautions Edward Taub, a behavioral psychologist at the University of Alabama, Birmingham (UAB). He and UAB rehabilitation psychologist Gitendra Uswatte are recruiting post–COVID-19 patients with cognitive impairment to a small pilot study of \"constraint-induced cognitive therapy,\" based on techniques Taub and colleagues first developed to help patients after strokes. It includes a video game that challenges a player's processing speed, as well as training on daily activities, such as making a shopping list or organizing medications, and monitored homework to help patients apply skills from the game to their lives.\nJackson knows brain training has its limits. But he argues that emerging evidence supports its value for building attention and processing skills, which he suspects are at the heart of many post–COVID-19 patients' impairments.\nSpudich, too, says she would welcome a web- or app-based attention-training game to help patients take charge of enduring COVID-19 symptoms against which they feel powerless. \"Frankly, I think those things will make a difference on outcomes, even if they're not proven in a clinical trial,\" she says. \"The hopelessness people feel in this situation is really palpable.\"","attrs_markdown":"[Skip to main content](https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments#main-content-focus)\n\n- [news](https:\/\/www.science.org\/news)\n- [careers](https:\/\/www.science.org\/careers)\n- [commentary](https:\/\/www.science.org\/commentary)\n- [Journals](https:\/\/www.science.org\/journals)\n\n[![](https:\/\/www.science.org\/pb-assets\/images\/styleguide\/logo-dark-1672180581427.svg) ![Science](https:\/\/www.science.org\/pb-assets\/images\/styleguide\/logo-1672180580750.svg)](https:\/\/www.science.org\/)\n\n- [Log in](https:\/\/www.science.org\/action\/ssostart?redirectUri=%2Fcontent%2Farticle%2Fcovid-19-brain-fog-inspires-search-causes-and-treatments)\n- [Become A Member](https:\/\/promo.aaas.org\/science\/join\/?CTC=SMHPJN)\n\n[![journal-menu-img](https:\/\/www.science.org\/cms\/asset\/ce70d779-babe-474b-bf8a-dac5fac45e2f\/science.2026.391.issue-6782.cover.gif)science](https:\/\/www.science.org\/journal\/science \"Science\")\n\n[![journal-menu-img](https:\/\/www.science.org\/cms\/asset\/27e14422-4415-4f18-89c7-a9c84ea35cec\/sciadv.2026.12.issue-3.cover.gif)science advances](https:\/\/www.science.org\/journal\/sciadv \"Science\")\n\n[![journal-menu-img](https:\/\/www.science.org\/cms\/asset\/cba30519-96c0-495c-9947-985829095f0c\/sciimmunol.2026.11.issue-115.cover.gif)science immunology](https:\/\/www.science.org\/journal\/sciimmunol \"Science\")\n\n[![journal-menu-img](https:\/\/www.science.org\/cms\/asset\/0a672c1f-b2bb-4a14-b414-475b8cb8174f\/scirobotics.2026.11.issue-110.cover.gif)science robotics](https:\/\/www.science.org\/journal\/scirobotics \"Science\")\n\n[![journal-menu-img](https:\/\/www.science.org\/cms\/asset\/e403a4d2-c06d-4053-84c2-488e56fe9e60\/signaling.2026.19.issue-920.cover.gif)science signaling](https:\/\/www.science.org\/journal\/signaling \"Science\")\n\n[![journal-menu-img](https:\/\/www.science.org\/cms\/asset\/dfc1c721-f0e5-40e8-90c4-d7bb696650c2\/stm.2026.18.issue-832.cover.gif)science translational medicine](https:\/\/www.science.org\/journal\/stm \"Science\")\n\n[![journal-menu-img](https:\/\/www.science.org\/pb-assets\/images\/styleguide\/spj-cover-1695403298717.png)science partner journals](https:\/\/spj.science.org\/ \"Science Partner Journals\")\n\nSearching:\n\nAnywhere\n\n[Anywhere](https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments#quick-search-form-9ea9b667-c3ce-40d1-870b-f7e001bbac01-0)[Science](https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments#quick-search-form-9ea9b667-c3ce-40d1-870b-f7e001bbac01-1)[Science Advances](https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments#quick-search-form-9ea9b667-c3ce-40d1-870b-f7e001bbac01-2)[Science Immunology](https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments#quick-search-form-9ea9b667-c3ce-40d1-870b-f7e001bbac01-3)[Science Robotics](https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments#quick-search-form-9ea9b667-c3ce-40d1-870b-f7e001bbac01-4)[Science Signaling](https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments#quick-search-form-9ea9b667-c3ce-40d1-870b-f7e001bbac01-5)[Science Translational Medicine](https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments#quick-search-form-9ea9b667-c3ce-40d1-870b-f7e001bbac01-6)\n\n[Advanced Search](https:\/\/www.science.org\/search\/advanced)\n\nSearch\n\n###### Trending Terms:\n- [cancer](https:\/\/www.science.org\/action\/doSearch?AllField=cancer)\n- [climate](https:\/\/www.science.org\/action\/doSearch?AllField=climate)\n- [artificial intelligence](https:\/\/www.science.org\/action\/doSearch?AllField=artificial%20intelligence)\n- [postdoc](https:\/\/www.science.org\/action\/doSearch?AllField=postdoc)\n- [aging](https:\/\/www.science.org\/action\/doSearch?AllField=aging)\n\n- [Log In](https:\/\/www.science.org\/action\/ssostart?redirectUri=\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments)\n\n- [Become A Member](https:\/\/promo.aaas.org\/science\/join\/?CTC=SMLDJN)\n- [Donate](https:\/\/www.science.org\/news\/donate?intcmp=sitemenu-donate&utm_id=recB0g01G48yiGSBD)\n\n[science.org](https:\/\/www.science.org\/)\n\n- [news](https:\/\/www.science.org\/news)\n  - [News Home](https:\/\/www.science.org\/news)\n  - [All News](https:\/\/www.science.org\/news\/all-news)\n  - [ScienceInsider](https:\/\/www.science.org\/news\/scienceinsider)\n  - [News Features](https:\/\/www.science.org\/news\/features)\n- [careers](https:\/\/www.science.org\/careers)\n- [commentary](https:\/\/www.science.org\/commentary)\n- [Journals](https:\/\/www.science.org\/journals)\n- [science](https:\/\/www.science.org\/journal\/science)\n- [science advances](https:\/\/www.science.org\/journal\/sciadv)\n- [science immunology](https:\/\/www.science.org\/journal\/sciimmunol)\n- [science robotics](https:\/\/www.science.org\/journal\/scirobotics)\n- [science signaling](https:\/\/www.science.org\/journal\/signaling)\n- [science translational medicine](https:\/\/www.science.org\/journal\/stm)\n- [science partner journals](https:\/\/spj.science.org\/)\n\n- [Custom publishing](https:\/\/www.science.org\/custom-publishing)\n- [prizes and awards](https:\/\/www.science.org\/content\/page\/prizes-and-awards)\n- [newsletters](https:\/\/www.science.org\/topic\/article-type\/scienceadviser?intcmp=menu-adviserfeed&utm_id=recI11u4srAIiGNLZ)\n- [collections](https:\/\/www.science.org\/collections)\n- [videos](https:\/\/www.science.org\/videos)\n- [podcasts](https:\/\/www.science.org\/podcasts)\n- [blogs](https:\/\/www.science.org\/blogs)\n- [visualizations](https:\/\/www.science.org\/visualizations)\n\n- [authors & reviewers](https:\/\/www.science.org\/content\/page\/contributing-science-family-journals)\n- [librarians](https:\/\/www.science.org\/content\/page\/librarian-portal)\n- [advertisers](https:\/\/advertising.sciencemag.org\/)\n- [about](https:\/\/www.science.org\/content\/page\/aboutus)\n- [help](https:\/\/www.science.org\/content\/page\/help)\n\n![AAAS Science Logo](https:\/\/www.science.org\/pb-assets\/images\/styleguide\/logo-1672180580750.svg)\n\n- [Terms of Service](https:\/\/www.science.org\/content\/page\/terms-service)\n- [Privacy Policy](https:\/\/www.science.org\/content\/page\/privacy-policy)\n- [Accessibility](https:\/\/www.science.org\/content\/page\/accessibility)\n\n- [News Home](https:\/\/www.science.org\/news)\n- [All News](https:\/\/www.science.org\/news\/all-news)\n- [ScienceInsider](https:\/\/www.science.org\/news\/scienceinsider)\n- [News Features](https:\/\/www.science.org\/news\/features)\n- [Donate](https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments#donation-blackbud-modal)\n\n[GET OUR E-ALERTS](https:\/\/www.science.org\/action\/showPreferences?menuTab=Alerts)\n\nMain content starts here\n\n[Home](https:\/\/www.science.org\/)[News](https:\/\/www.science.org\/news)[ScienceInsider](https:\/\/www.science.org\/news\/scienceinsider)COVID-19 ‘brain fog' inspires search for causes and treatments\n\n[Back To ScienceInsider](https:\/\/www.science.org\/news\/scienceinsider)\n\n- [ScienceInsider](https:\/\/www.science.org\/news\/scienceinsider \"ScienceInsider\")\n- [Health](https:\/\/www.science.org\/topic\/category\/health)\n\n# COVID-19 ‘brain fog' inspires search for causes and treatments\n## Disentangling the roots of survivors’ cognitive deficits is no easy task\n\n- 27 Apr 2021\n- By[Kelly Servick](https:\/\/www.science.org\/content\/author\/kelly-servick \"Kelly Servick\")\n\n![conceptual illustration of a viruses and clouds in the air around a woman wearing a mask](https:\/\/www.science.org\/cms\/asset\/17f16225-aa68-405f-a9d0-f800ea155da9\/main_brainfog_1280p.jpg)\n\nPonomariova\\_Maria\/iStock\n\nShare:\n\n- [Facebook](https:\/\/www.science.org\/#facebook \"Facebook\")\n- [Share on X](https:\/\/www.science.org\/#twitter \"Share on X\")\n- [Linked In](https:\/\/www.science.org\/#linkedin \"Linked In\")\n- [Reddit](https:\/\/www.science.org\/#reddit \"Reddit\")\n- [Wechat](https:\/\/www.science.org\/#wechat \"Wechat\")\n- [Whatsapp](https:\/\/www.science.org\/#whatsapp \"Whatsapp\")\n- [Email](https:\/\/www.science.org\/#email \"Email\")\n\n**Science's COVID-19 reporting is supported by the Heising-Simons Foundation.**\n\nSince she fell ill with COVID-19 around Thanksgiving, Pamela Furr has been waiting for her old self to return. A radio news anchor in Tennessee for more than 10 years, she now sometimes finds herself stuck midsentence grasping for simple words; she is prone to forget events and conversations if she doesn't write them down. \"I'm not the same person that I was before COVID,\" she says. \"I kind of miss me.\"\n\nThe true prevalence of cognitive problems in COVID-19 survivors is elusive, and the underlying causes of lingering symptoms [are the subject of ongoing studies](https:\/\/www.sciencemag.org\/news\/2021\/04\/how-scientists-are-teasing-apart-biology-long-covid). But it's now clear that trouble thinking, concentrating, and remembering can be among the most debilitating \"long-haul\" symptoms and can persist for months. As more and more people seek help to overcome their brain fog at clinics set up for post–COVID-19 care, researchers and physicians are turning to treatments developed for stroke and traumatic brain injuries. And a few are setting out to test cognitive training video games they hope will expand the reach of therapy.\n\n\"Even if it's a fairly small percentage \\[of survivors\\] who report cognitive problems, the number of overall people in that category … represents a tremendous problem,\" says James Jackson, a clinical psychologist at the Vanderbilt University School of Medicine's ICU Recovery Center, where Furr will participate in a support group for COVID-19 long haulers.\n\nCognitive impairment is common after serious illness. It's among the symptoms of a condition called [post–intensive care syndrome](https:\/\/www.sciencemag.org\/news\/2020\/04\/survivors-severe-covid-19-beating-virus-just-beginning) that can follow the isolation, immobility, and sedation of a hospital stay. And severe COVID-19 can itself damage the brain during its acute phase. SARS-CoV-2 may rarely invade brain tissue directly; most neurological damage is thought to stem from the indirect effects of infection, such as inflammation, stroke, and lack of oxygen.\n\n\"I'm not sure that what we're seeing post-COVID is different\" from impairments after other serious respiratory illnesses, says Faith Gunning, a neuropsychologist at Weill Cornell Medicine (WCM). She and colleagues reported in February that of 57 recovering COVID-19 patients referred for neuropsychological evaluation before hospital discharge, [81% had cognitive impairment](https:\/\/www.nature.com\/articles\/s41386-021-00978-8). Most experienced problems with attention and executive function, which includes skills like planning, organization, and multitasking.\n\n#### Advertisement\nAnd such symptoms aren't limited to people who wound up hospitalized. The majority of people visiting post–COVID-19 outpatient clinics had a relatively mild acute phase of illness, says Igor Koralnik, a neurologist at Northwestern University's Feinberg School of Medicine. He oversees the Neuro COVID-19 Clinic at Northwestern Memorial Hospital, which has seen more than 400 patients since it opened in May 2020. Among the first 100 patients with confirmed COVID-19 infections whose symptoms lasted at least 6 weeks, [81 experienced \"brain fog,\"](https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/acn3.51350) the most common neurologic symptom, Koralnik's team reported last month in the Annals of Clinical and Translational Neurology.\n\nAfter brain injury, cognitive rehab typically involves testing to identify cognitive weaknesses and training to help patients navigate daily life. Often, the focus is on compensating for deficits, not eliminating them outright. Jackson's team at Vanderbilt recommends a rehabilitation program called goal management training, originally developed to manage impairments after stroke, traumatic brain injury, or age-related decline. It trains patients in \"metacognitive skills\" such as observing their own thought processes, identifying situations where they're prone to make cognitive errors, and reflecting on how to approach a new task.\n\nIt can be \"a game changer\" for patients, Jackson says. He expects such training to benefit people with post–COVID-19 impairments—but only if their primary care physicians refer them as they would people who had a stroke or traumatic injury. For now, that happens rarely, he says.\n\n![quotation mark](https:\/\/www.science.org\/pb-assets\/images\/styleguide\/quotation-mark-1746033675637.svg)\n\nAny time you're developing a treatment, you need to understand the mechanism. But we can't afford to wait. We need to do something now.\n\n- Ana-Maria Vranceanu, Harvard Medical School\n\nComplicating matters for doctors is that the nature of the injuries is often far from clear. \"We don't really know what happened to them,\" says Serena Spudich, an infectious disease neurologist at the Yale School of Medicine. When cognitive dysfunction appears after mild COVID-19, it raises the possibility that an immune response that was protective in the acute phase has become overactive and triggered continuing inflammation, she says. Spudich leads a study using brain imaging along with analyses of spinal fluid and other biological samples to look for signs of inflammation and other abnormalities in patients with persistent post–COVID-19 neurological symptoms.\n\nThere are other possible explanations for cognitive impairments. \"Things like sleep and exhaustion, pain and stress and depression—all of these nonneurological issues also play a role in our cognitive functioning,\" says Renee Madathil, a rehabilitation neuropsychologist at the University of Rochester Medical Center. Cognitive impairments rooted in depression or stress aren't any less \"real\" than those caused by direct injury to the brain, Madathil and others stress. But different causes may call for different therapies.\n\n\"Any time you're developing a treatment, you need to understand the mechanism,\" says Ana-Maria Vranceanu, a clinical health psychologist at Harvard Medical School. \"But we can't afford to wait,\" she adds. \"We need to do something now.\" In prepandemic studies of intensive care unit (ICU) survivors, her team found that elevated emotional distress spelled a slower recovery. Her team developed a training program to help ICU survivors and their families manage distress, anxiety, and depression, which she aims to adapt for COVID-19 recovery.\n\nTo help people who neither live near rehabilitation centers nor have access to specialists, a few researchers are exploring a newer category of potential treatments: cognitive training through video games played at home.\n\nIn response to what he calls \"a tsunami of patients with Long COVID,\" Radboud University Medical Center professor of surgery Harry van Goor, with Radboud physical therapy researcher Bart Staal, is testing a virtual reality platform and a set of games that involve physical activity, cognitive skills, and mindfulness. A pilot study in 48 people recovering from COVID-19 suggests the puzzlelike cognitive games were highly motivating, the researchers say; they next hope to launch a controlled trial of the approach versus traditional rehab.\n\nMeanwhile, Jackson's team at Vanderbilt and Gunning's at WCM are gearing up to test a \"digital treatment\" developed by Akili Interactive, which last year became the first company to win approval from the U.S. Food and Drug Administration for a video game as a prescription therapy.\n\nThe technology, so far approved for attention deficit hyperactivity disorder (ADHD), \"is not just a blunderbuss approach\" to treat any condition that involves cognitive dysfunction, says Anil Jina, Akili's chief medical officer. Instead, it's designed to improve attention—for example, by having players multitask to collect items in the game while avoiding obstacles. A study of more than 300 children with ADHD published last year showed that those who played the game [showed greater improvements](https:\/\/www.thelancet.com\/journals\/landig\/article\/PIIS2589-7500\$20\$30017-0\/fulltext) in computerized attention tests and on parent and clinician assessments than those who used an educational video game.\n\n![A racing video game set underwater](https:\/\/www.science.org\/cms\/asset\/58daad4d-f7b5-4c49-9d61-2c8b4f6420b4\/secondary_endeavor_soup_1280p.jpg)\n\nA video game developed by Akili Interactive challenges attention with a series of targets and obstacles.\n\nAkili Interactive\n\nGunning's study, set to launch next month, aims to include 100 participants who have lingering cognitive deficits after COVID-19; Jackson's group expects to include more than 50 people with such symptoms. In both studies, half the participants will be assigned to 6 weeks of at-home play. Half will serve as controls but will have access to the game after the assessment is complete.\n\nThe brain-training industry [has a checkered reputation](https:\/\/science.sciencemag.org\/content\/351\/6270\/212.full) when it comes to science. In 2016, Lumos Labs, the company behind the popular program Lumosity, agreed to pay the Federal Trade Commission \\$2 million to settle false advertising charges after promoting its games as a way to stave off Alzheimer's disease and other conditions without adequate evidence.\n\nIn studies of cognitive decline accompanying aging, puzzles and cognitive games haven't proved as effective as physical activity and an active social life, Vranceanu notes. \"If you're doing Sudoku, you're getting good at Sudoku,\" she says, \"but that doesn't necessarily translate to you getting better at not misplacing your keys.\"\n\nAnd in rehabilitation, the transfer of skills from games and exercises in the clinic to everyday life \"does not occur easily,\" cautions Edward Taub, a behavioral psychologist at the University of Alabama, Birmingham (UAB). He and UAB rehabilitation psychologist Gitendra Uswatte are recruiting post–COVID-19 patients with cognitive impairment to a small pilot study of \"constraint-induced cognitive therapy,\" based on techniques Taub and colleagues first developed to help patients after strokes. It includes a video game that challenges a player's processing speed, as well as training on daily activities, such as making a shopping list or organizing medications, and monitored homework to help patients apply skills from the game to their lives.\n\nJackson knows brain training has its limits. But he argues that emerging evidence supports its value for building attention and processing skills, which he suspects are at the heart of many post–COVID-19 patients' impairments.\n\nSpudich, too, says she would welcome a web- or app-based attention-training game to help patients take charge of enduring COVID-19 symptoms against which they feel powerless. \"Frankly, I think those things will make a difference on outcomes, even if they're not proven in a clinical trial,\" she says. \"The hopelessness people feel in this situation is really palpable.\"\n***\n\ndoi: 10.1126\/science.abj2105\n\n#### Relevant tags:\n[Health](https:\/\/www.science.org\/topic\/category\/health \"Health\") [Coronavirus](https:\/\/www.science.org\/topic\/tags\/coronavirus \"Coronavirus\")\n## About the author\n![Kelly Servick](https:\/\/www.science.org\/cms\/asset\/a550405f-1c4c-40af-8a6e-6a7c181ed3da\/kellyservick-headshot.jpg)\n\n#### [Kelly Servick](https:\/\/www.science.org\/content\/author\/kelly-servick)\n[mail](mailto:kservick@aaas.org \"mail\")[Share on X](https:\/\/www.twitter.com\/@kellyservick \"Share on X\")\n##### Author\nKelly Servick is a staff writer at *Science*.\n\n[View more](https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments)\n## More from news\n[![An illustration of a microscope examining a row of papers](https:\/\/www.science.org\/cms\/asset\/fa01746c-9f8e-44ff-b523-b5dc1d1d91ad\/_20260116__on_scrutinzingpapers.jpg)](https:\/\/www.science.org\/content\/article\/some-guest-editors-pack-special-issues-their-own-articles \"Some guest editors pack special issues with their own articles\")\n\n16 Jan 2026\n\n[Some guest editors pack special issues with their own articles](https:\/\/www.science.org\/content\/article\/some-guest-editors-pack-special-issues-their-own-articles \"Some guest editors pack special issues with their own articles\")\n\nBy\n\n- Jeffrey Brainard\n\n[![Purdue University campus](https:\/\/www.science.org\/cms\/asset\/5ad91c48-8225-4203-af3f-b2601291ef40\/_20260114_on_purdue.jpg)](https:\/\/www.science.org\/content\/article\/purdue-blocks-admission-many-chinese-grad-students-unwritten-policy \"Purdue blocks admission of many Chinese grad students in unwritten policy\")\n\n16 Jan 2026\n\n[Purdue blocks admission of many Chinese grad students in unwritten policy](https:\/\/www.science.org\/content\/article\/purdue-blocks-admission-many-chinese-grad-students-unwritten-policy \"Purdue blocks admission of many Chinese grad students in unwritten policy\")\n\nBy\n\n- Jeffrey Mervis\n\n[![Ring nebula](https:\/\/www.science.org\/cms\/asset\/523444aa-2275-43ab-ba90-3e3ceee5b93c\/_20260115_on_ring_nebula_lede.jpg)](https:\/\/www.science.org\/content\/article\/did-vaporized-alien-planet-leave-behind-strange-iron-bar \"Did a vaporized alien planet leave behind a strange iron ‘bar’?\")\n\n15 Jan 2026\n\n[Did a vaporized alien planet leave behind a strange iron ‘bar’?](https:\/\/www.science.org\/content\/article\/did-vaporized-alien-planet-leave-behind-strange-iron-bar \"Did a vaporized alien planet leave behind a strange iron ‘bar’?\")\n\nBy\n\n- Jenna Ahart\n\n[View more](https:\/\/www.science.org\/news\/all-news)\n\nGot a tip for Science's news department?   [Connect](https:\/\/www.science.org\/content\/page\/got-tip)\n\n### Sign up for ScienceAdviser\nGet Science’s award-winning newsletter with the latest news, commentary, and research, free to your inbox daily.\n\n[Subscribe](https:\/\/www.science.org\/content\/page\/scienceadviser?intcmp=rrail-adviser&utm_id=recFUzjFNRznSEEDd)\n\n## ScienceInsider\n[![An illustration of a microscope examining a row of papers](https:\/\/www.science.org\/cms\/asset\/fa01746c-9f8e-44ff-b523-b5dc1d1d91ad\/_20260116__on_scrutinzingpapers.jpg)](https:\/\/www.science.org\/content\/article\/some-guest-editors-pack-special-issues-their-own-articles \"Some guest editors pack special issues with their own articles\")\n\n16 Jan 2026\n\nBy\n\n- Jeffrey Brainard\n\n[Some guest editors pack special issues with their own articles](https:\/\/www.science.org\/content\/article\/some-guest-editors-pack-special-issues-their-own-articles \"Some guest editors pack special issues with their own articles\")\n\n[![Purdue University campus](https:\/\/www.science.org\/cms\/asset\/5ad91c48-8225-4203-af3f-b2601291ef40\/_20260114_on_purdue.jpg)](https:\/\/www.science.org\/content\/article\/purdue-blocks-admission-many-chinese-grad-students-unwritten-policy \"Purdue blocks admission of many Chinese grad students in unwritten policy\")\n\n16 Jan 2026\n\nBy\n\n- Jeffrey Mervis\n\n[Purdue blocks admission of many Chinese grad students in unwritten policy](https:\/\/www.science.org\/content\/article\/purdue-blocks-admission-many-chinese-grad-students-unwritten-policy \"Purdue blocks admission of many Chinese grad students in unwritten policy\")\n\n[![Pampas Verdes](https:\/\/www.science.org\/cms\/asset\/710419b8-15d4-4827-9cb0-1eb17d9391a6\/_20260114_on_peru_mining_lede.jpg)](https:\/\/www.science.org\/content\/article\/illegal-miners-have-forced-peru-s-oldest-environmental-research-station-suspend-work \"Illegal miners have forced Peru’s oldest environmental research station to suspend work\")\n\n15 Jan 2026\n\nBy\n\n- Kata Karáth\n\n[Illegal miners have forced Peru’s oldest environmental research station to suspend work](https:\/\/www.science.org\/content\/article\/illegal-miners-have-forced-peru-s-oldest-environmental-research-station-suspend-work \"Illegal miners have forced Peru’s oldest environmental research station to suspend work\")\n\n[![Bethany Hickey holds her 6 month old son, Alexander while he receives a Prevnar Pneumococcal Meningitis vaccine](https:\/\/www.science.org\/cms\/asset\/dd3cf634-637e-4915-a3d4-6f9644184e50\/_20250108_on_trump_vaccines.jpg)](https:\/\/www.science.org\/content\/article\/trump-administration-says-some-approved-childhood-vaccines-need-better-studies \"The Trump administration says some approved childhood vaccines need better studies. Scientists disagree\")\n\n8 Jan 2026\n\nBy\n\n- Jon Cohen\n\n[The Trump administration says some approved childhood vaccines need better studies. Scientists disagree](https:\/\/www.science.org\/content\/article\/trump-administration-says-some-approved-childhood-vaccines-need-better-studies \"The Trump administration says some approved childhood vaccines need better studies. Scientists disagree\")\n\n[View more](https:\/\/www.science.org\/news\/scienceinsider)\n\n## Sifter\n[![fMRI image of preteen brain](https:\/\/www.science.org\/cms\/asset\/6f3fa20c-bfd8-4a2b-8660-95871cc9a84f\/_sf_brainmapping.jpg)](https:\/\/www.science.org\/content\/article\/flaw-brain-mapping-technique-may-undercut-neuroscience-findings \"Flaw in brain-mapping technique may undercut neuroscience findings\")\n\n16 Jan 2026\n\nBy\n\n- Catherine Offord\n\n[Flaw in brain-mapping technique may undercut neuroscience findings](https:\/\/www.science.org\/content\/article\/flaw-brain-mapping-technique-may-undercut-neuroscience-findings \"Flaw in brain-mapping technique may undercut neuroscience findings\")\n\n[![Ground rosettes](https:\/\/www.science.org\/cms\/asset\/09c8cf4d-d2a8-4e48-9d8c-1353bc15a850\/arabidopsis_thaliana_sifter.jpg)](https:\/\/www.science.org\/content\/article\/plants-cope-stress-touching-each-other \"Plants cope with stress by touching each other\")\n\n15 Jan 2026\n\nBy\n\n- Claudia Steiner\n\n[Plants cope with stress by touching each other](https:\/\/www.science.org\/content\/article\/plants-cope-stress-touching-each-other \"Plants cope with stress by touching each other\")\n\n[![A plastic bag for biohazard waste](https:\/\/www.science.org\/cms\/asset\/22c8c5d9-6e09-432f-a5fb-0e6abf5558b9\/_sf_labsafety.jpg)](https:\/\/www.science.org\/content\/article\/leading-ai-models-miss-dangerous-lab-risks \"Leading AI models miss dangerous lab risks\")\n\n15 Jan 2026\n\nBy\n\n- Celina Zhao\n\n[Leading AI models miss dangerous lab risks](https:\/\/www.science.org\/content\/article\/leading-ai-models-miss-dangerous-lab-risks \"Leading AI models miss dangerous lab risks\")\n\n[![Galápagos sea lion](https:\/\/www.science.org\/cms\/asset\/043732cc-6747-47a2-b90f-19c2ac923a19\/_sf_sealion.jpg)](https:\/\/www.science.org\/content\/article\/some-nursing-sea-lions-it-s-never-too-old-mom \"For some nursing sea lions, it’s never too old for mom\")\n\n13 Jan 2026\n\nBy\n\n- Alessio Cozzolino\n\n[For some nursing sea lions, it’s never too old for mom](https:\/\/www.science.org\/content\/article\/some-nursing-sea-lions-it-s-never-too-old-mom \"For some nursing sea lions, it’s never too old for mom\")\n\n[View more](https:\/\/www.science.org\/news\/sifter)\n\n## Recommended[Close](https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments)\nIn Depth\n\nMarch 2020\n\n[Race to find COVID-19 treatments accelerates](https:\/\/www.science.org\/doi\/full\/10.1126\/science.367.6485.1412 \"Race to find COVID-19 treatments accelerates\")\n\nEditorial\n\nMay 2020\n\n[COVID-19 amidst Ebola's retreat](https:\/\/www.science.org\/doi\/full\/10.1126\/science.abc4859 \"COVID-19 amidst Ebola's retreat\")\n\nEditorial\n\nJune 2020\n\n[COVID-19 and flu, a perfect storm](https:\/\/www.science.org\/doi\/full\/10.1126\/science.abd2220 \"COVID-19 and flu, a perfect storm\")\n\nEditorial\n\nJuly 2020\n\n[COVID-19 and the next influenza season](https:\/\/www.science.org\/doi\/full\/10.1126\/sciadv.abd0086 \"COVID-19 and the next influenza season\")\n\nSPONSORED [webinar](https:\/\/www.science.org\/custom-publishing\/webinars \"webinars\")\n\nScience and Life 18 Dec 2025\n\n[Building a global community for rare disease: Accelerating treatments, access, and collaboration](https:\/\/www.science.org\/content\/webinar\/building-global-community-rare-disease-accelerating-treatments-access-and-collaboration \"Building a global community for rare disease: Accelerating treatments, access, and collaboration\")\n\n![](https:\/\/www.science.org\/specs\/products\/aaas\/releasedAssets\/images\/logo-dark-5054d3662e2bdb9b57c1aa182d7a711e.svg)\n\n×\n\n##### Support nonprofit science journalism\nAmid the unprecedented upheaval in U.S. science, hard-hitting, trustworthy reporting has never been more important. As part of the AAAS mission, *Science* has built a global award-winning network of reporters and editors that independently cover the most important developments in research and policy.\n\nYour tax-deductible contribution plays a critical role in sustaining this effort.\n\nIf, at any time, you would like to stop or make changes to your monthly gift, please contact the Philanthropy Office at [philanthropy@aaas.org](mailto:philanthropy@aaas.org) or 202-326-6636.\n\n[Charitable Disclosures](https:\/\/www.aaas.org\/governance\/disclosures)\n\nLoading...\n\n[Skip slideshow](https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments#afterSlideshow-j3n)\n\n###### [Follow Us](https:\/\/www.science.org\/content\/page\/science-family-journals-social-media)\n- [Get our newsletter](https:\/\/www.science.org\/content\/page\/scienceadviser?intcmp=ftr-adviser&utm_id=recdExfxt1yeSJxzi)\n\n- [NEWS](https:\/\/www.science.org\/news)\n- [All News](https:\/\/www.science.org\/news\/all-news)\n- [ScienceInsider](https:\/\/www.science.org\/news\/scienceinsider)\n- [News Features](https:\/\/www.science.org\/news\/features)\n- [Subscribe to News from Science](https:\/\/www.science.org\/content\/page\/news-science-subscriptions?intcmp=footer-subscribetonews&utm_id=recziGpGO7jMVeez2)\n- [News from Science FAQ](https:\/\/www.science.org\/content\/page\/news-subscriber-faqs)\n- [About News from Science](https:\/\/www.science.org\/content\/page\/about-news-science)\n- [Donate to News](https:\/\/www.science.org\/news\/donate?intcmp=footer-donate&utm_id=recVQVKKRRLdidlGT)\n\n- [CAREERS](https:\/\/www.science.org\/careers)\n- [Careers Articles](https:\/\/www.science.org\/topic\/article-type\/careers-editorial)\n- [Find Jobs](https:\/\/jobs.sciencecareers.org\/)\n- [Employer Hubs](https:\/\/www.science.org\/careers\/employers)\n\n- [COMMENTARY](https:\/\/www.science.org\/commentary)\n- [Opinion](https:\/\/www.science.org\/commentary\/opinion)\n- [Analysis](https:\/\/www.science.org\/commentary\/analysis)\n- [Blogs](https:\/\/www.science.org\/blogs)\n\n- [JOURNALS](https:\/\/www.science.org\/journals)\n- [Science](https:\/\/www.science.org\/journal\/science)\n- [Science Advances](https:\/\/www.science.org\/journal\/sciadv)\n- [Science Immunology](https:\/\/www.science.org\/journal\/sciimmunol)\n- [Science Robotics](https:\/\/www.science.org\/journal\/scirobotics)\n- [Science Signaling](https:\/\/www.science.org\/journal\/signaling)\n- [Science Translational Medicine](https:\/\/www.science.org\/journal\/stm)\n- [Science Partner Journals](https:\/\/spj.sciencemag.org\/)\n\n- [AUTHORS & REVIEWERS](https:\/\/www.science.org\/content\/page\/contributing-science-family-journals)\n- [Information for Authors](https:\/\/www.science.org\/content\/page\/contributing-science-family-journals)\n- [Information for Reviewers](https:\/\/www.science.org\/content\/page\/peer-review-science-publications)\n\n- [LIBRARIANS](https:\/\/www.science.org\/content\/page\/librarian-portal)\n- [Manage Your Institutional Subscription](https:\/\/www.science.org\/action\/institutionAccessEntitlements)\n- [Library Admin Portal](https:\/\/www.science.org\/content\/page\/librarian-portal)\n- [Request a Quote](https:\/\/scienceaaas.org\/request)\n- [Librarian FAQs](https:\/\/www.science.org\/content\/page\/librarian-portal-frequently-asked-questions)\n\n- [ADVERTISERS](https:\/\/advertising.sciencemag.org\/)\n- [Advertising Kits](https:\/\/advertising.sciencemag.org\/)\n- [Custom Publishing Info](https:\/\/www.science.org\/custom-publishing)\n- [Post a Job](https:\/\/employers.sciencecareers.org\/)\n\n- [RELATED SITES](https:\/\/www.science.org\/content\/page\/related-sites)\n- [AAAS.org](https:\/\/www.aaas.org\/)\n- [AAAS Communities](https:\/\/members.aaas.org\/home)\n- [EurekAlert\\!](https:\/\/www.eurekalert.org\/)\n- [Science in the Classroom](https:\/\/www.scienceintheclassroom.org\/)\n\n- [ABOUT US](https:\/\/www.science.org\/content\/page\/aboutus)\n- [Leadership](https:\/\/www.science.org\/content\/page\/leadership-and-management)\n- [Work at AAAS](https:\/\/www.aaas.org\/careers\/workataaas)\n- [Prizes and Awards](https:\/\/www.science.org\/content\/page\/prizes-and-awards)\n\n- [HELP](https:\/\/www.science.org\/content\/page\/help)\n- [FAQs](https:\/\/www.science.org\/content\/page\/faqs)\n- [Access and Subscriptions](https:\/\/www.science.org\/content\/page\/access-and-subscriptions)\n- [Order a Single Issue](https:\/\/backissues.science.org\/)\n- [Reprints and Permissions](https:\/\/www.science.org\/content\/page\/reprints-and-permissions)\n- [TOC Alerts and RSS Feeds](https:\/\/www.science.org\/content\/page\/email-alerts-and-rss-feeds)\n- [Contact Us](https:\/\/www.science.org\/content\/page\/contact-us)\n\n###### [Follow Us](https:\/\/www.science.org\/content\/page\/science-family-journals-social-media)\n[Get our newsletter](https:\/\/www.science.org\/content\/page\/scienceadviser?intcmp=ftr-adviser&utm_id=recdExfxt1yeSJxzi)\n\n[![AAAS logo](https:\/\/www.science.org\/pb-assets\/images\/styleguide\/aaas-logo-1672180581667.svg)](https:\/\/www.aaas.org\/ \"Visit the AAAS homepage\")\n\n© 2026 American Association for the Advancement of Science. All rights reserved. AAAS is a partner of HINARI, AGORA, OARE, CHORUS, CLOCKSS, CrossRef and COUNTER.\n\nback to top\n\n- [Terms of Service](https:\/\/www.science.org\/content\/page\/terms-service \"Terms of Service\")\n- [Privacy Policy](https:\/\/www.science.org\/content\/page\/privacy-policy \"Privacy Policy\")\n- [Cookie Preferences](https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments#cookie-preferences \"Cookie Preferences\")\n- [Accessibility](https:\/\/www.science.org\/content\/page\/accessibility \"Accessibility\")\n\n![news-white-logo](https:\/\/www.science.org\/pb-assets\/images\/popup-logos\/news-white-logo-1712047935.png)\n\n×\n\n[![AAAS Annual Meeting](https:\/\/www.science.org\/pb-assets\/images\/logos\/AAAS-AM26-LogoBlue-1768408324583.png)](https:\/\/meetings.aaas.org\/attend-phx\/registration\/?utm_medium=display&utm_source=membership-website&utm_campaign=am2026&utm_content=reg&utm_id=recOPRLd3NNbUXuLe)\n\nJoin us in Phoenix 12–14 February to define where science goes next. Register by 22 January for lowest rate.\n\n[Register](https:\/\/meetings.aaas.org\/attend-phx\/registration\/?utm_medium=display&utm_source=membership-website&utm_campaign=am2026&utm_content=reg&utm_id=recOPRLd3NNbUXuLe)[Not Now](https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments)\n\n✓\n\nThanks for sharing\\!\n\n[AddToAny](https:\/\/www.addtoany.com\/ \"Share Buttons\")\n\n[More…](https:\/\/www.science.org\/content\/article\/covid-19-brain-fog-inspires-search-causes-and-treatments#addtoany \"Show all\")","attrs_readable_markdown":null,"meta_canonical":null}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📄

INDEXABLE

✅

CRAWLED

3 months ago

🤖

ROBOTS ALLOWED

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	PASS	`download_stamp > now() - 6 MONTH`	3.1 months ago
History drop	PASS	`isNull(history_drop_reason)`	No drop reason
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property	Value
URL	https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments
Last Crawled	2026-01-17 04:02:14 (3 months ago)
First Indexed	2021-10-14 16:00:24 (4 years ago)
HTTP Status Code	200
Meta Title	COVID-19 ‘brain fog' inspires search for causes and treatments \| Science \| AAAS
Meta Description	null
Meta Canonical	null
Boilerpipe Text	Science 's COVID-19 reporting is supported by the Heising-Simons Foundation. Since she fell ill with COVID-19 around Thanksgiving, Pamela Furr has been waiting for her old self to return. A radio news anchor in Tennessee for more than 10 years, she now sometimes finds herself stuck midsentence grasping for simple words; she is prone to forget events and conversations if she doesn't write them down. "I'm not the same person that I was before COVID," she says. "I kind of miss me." The true prevalence of cognitive problems in COVID-19 survivors is elusive, and the underlying causes of lingering symptoms are the subject of ongoing studies . But it's now clear that trouble thinking, concentrating, and remembering can be among the most debilitating "long-haul" symptoms and can persist for months. As more and more people seek help to overcome their brain fog at clinics set up for post–COVID-19 care, researchers and physicians are turning to treatments developed for stroke and traumatic brain injuries. And a few are setting out to test cognitive training video games they hope will expand the reach of therapy. "Even if it's a fairly small percentage [of survivors] who report cognitive problems, the number of overall people in that category … represents a tremendous problem," says James Jackson, a clinical psychologist at the Vanderbilt University School of Medicine's ICU Recovery Center, where Furr will participate in a support group for COVID-19 long haulers. Cognitive impairment is common after serious illness. It's among the symptoms of a condition called post–intensive care syndrome that can follow the isolation, immobility, and sedation of a hospital stay. And severe COVID-19 can itself damage the brain during its acute phase. SARS-CoV-2 may rarely invade brain tissue directly; most neurological damage is thought to stem from the indirect effects of infection, such as inflammation, stroke, and lack of oxygen. "I'm not sure that what we're seeing post-COVID is different" from impairments after other serious respiratory illnesses, says Faith Gunning, a neuropsychologist at Weill Cornell Medicine (WCM). She and colleagues reported in February that of 57 recovering COVID-19 patients referred for neuropsychological evaluation before hospital discharge, 81% had cognitive impairment . Most experienced problems with attention and executive function, which includes skills like planning, organization, and multitasking. And such symptoms aren't limited to people who wound up hospitalized. The majority of people visiting post–COVID-19 outpatient clinics had a relatively mild acute phase of illness, says Igor Koralnik, a neurologist at Northwestern University's Feinberg School of Medicine. He oversees the Neuro COVID-19 Clinic at Northwestern Memorial Hospital, which has seen more than 400 patients since it opened in May 2020. Among the first 100 patients with confirmed COVID-19 infections whose symptoms lasted at least 6 weeks, 81 experienced "brain fog," the most common neurologic symptom, Koralnik's team reported last month in the Annals of Clinical and Translational Neurology . After brain injury, cognitive rehab typically involves testing to identify cognitive weaknesses and training to help patients navigate daily life. Often, the focus is on compensating for deficits, not eliminating them outright. Jackson's team at Vanderbilt recommends a rehabilitation program called goal management training, originally developed to manage impairments after stroke, traumatic brain injury, or age-related decline. It trains patients in "metacognitive skills" such as observing their own thought processes, identifying situations where they're prone to make cognitive errors, and reflecting on how to approach a new task. It can be "a game changer" for patients, Jackson says. He expects such training to benefit people with post–COVID-19 impairments—but only if their primary care physicians refer them as they would people who had a stroke or traumatic injury. For now, that happens rarely, he says. Any time you're developing a treatment, you need to understand the mechanism. But we can't afford to wait. We need to do something now. Ana-Maria Vranceanu, Harvard Medical School Complicating matters for doctors is that the nature of the injuries is often far from clear. "We don't really know what happened to them," says Serena Spudich, an infectious disease neurologist at the Yale School of Medicine. When cognitive dysfunction appears after mild COVID-19, it raises the possibility that an immune response that was protective in the acute phase has become overactive and triggered continuing inflammation, she says. Spudich leads a study using brain imaging along with analyses of spinal fluid and other biological samples to look for signs of inflammation and other abnormalities in patients with persistent post–COVID-19 neurological symptoms. There are other possible explanations for cognitive impairments. "Things like sleep and exhaustion, pain and stress and depression—all of these nonneurological issues also play a role in our cognitive functioning," says Renee Madathil, a rehabilitation neuropsychologist at the University of Rochester Medical Center. Cognitive impairments rooted in depression or stress aren't any less "real" than those caused by direct injury to the brain, Madathil and others stress. But different causes may call for different therapies. "Any time you're developing a treatment, you need to understand the mechanism," says Ana-Maria Vranceanu, a clinical health psychologist at Harvard Medical School. "But we can't afford to wait," she adds. "We need to do something now." In prepandemic studies of intensive care unit (ICU) survivors, her team found that elevated emotional distress spelled a slower recovery. Her team developed a training program to help ICU survivors and their families manage distress, anxiety, and depression, which she aims to adapt for COVID-19 recovery. To help people who neither live near rehabilitation centers nor have access to specialists, a few researchers are exploring a newer category of potential treatments: cognitive training through video games played at home. In response to what he calls "a tsunami of patients with Long COVID," Radboud University Medical Center professor of surgery Harry van Goor, with Radboud physical therapy researcher Bart Staal, is testing a virtual reality platform and a set of games that involve physical activity, cognitive skills, and mindfulness. A pilot study in 48 people recovering from COVID-19 suggests the puzzlelike cognitive games were highly motivating, the researchers say; they next hope to launch a controlled trial of the approach versus traditional rehab. Meanwhile, Jackson's team at Vanderbilt and Gunning's at WCM are gearing up to test a "digital treatment" developed by Akili Interactive, which last year became the first company to win approval from the U.S. Food and Drug Administration for a video game as a prescription therapy. The technology, so far approved for attention deficit hyperactivity disorder (ADHD), "is not just a blunderbuss approach" to treat any condition that involves cognitive dysfunction, says Anil Jina, Akili's chief medical officer. Instead, it's designed to improve attention—for example, by having players multitask to collect items in the game while avoiding obstacles. A study of more than 300 children with ADHD published last year showed that those who played the game showed greater improvements in computerized attention tests and on parent and clinician assessments than those who used an educational video game. A video game developed by Akili Interactive challenges attention with a series of targets and obstacles. Akili Interactive Gunning's study, set to launch next month, aims to include 100 participants who have lingering cognitive deficits after COVID-19; Jackson's group expects to include more than 50 people with such symptoms. In both studies, half the participants will be assigned to 6 weeks of at-home play. Half will serve as controls but will have access to the game after the assessment is complete. The brain-training industry has a checkered reputation when it comes to science. In 2016, Lumos Labs, the company behind the popular program Lumosity, agreed to pay the Federal Trade Commission $2 million to settle false advertising charges after promoting its games as a way to stave off Alzheimer's disease and other conditions without adequate evidence. In studies of cognitive decline accompanying aging, puzzles and cognitive games haven't proved as effective as physical activity and an active social life, Vranceanu notes. "If you're doing Sudoku, you're getting good at Sudoku," she says, "but that doesn't necessarily translate to you getting better at not misplacing your keys." And in rehabilitation, the transfer of skills from games and exercises in the clinic to everyday life "does not occur easily," cautions Edward Taub, a behavioral psychologist at the University of Alabama, Birmingham (UAB). He and UAB rehabilitation psychologist Gitendra Uswatte are recruiting post–COVID-19 patients with cognitive impairment to a small pilot study of "constraint-induced cognitive therapy," based on techniques Taub and colleagues first developed to help patients after strokes. It includes a video game that challenges a player's processing speed, as well as training on daily activities, such as making a shopping list or organizing medications, and monitored homework to help patients apply skills from the game to their lives. Jackson knows brain training has its limits. But he argues that emerging evidence supports its value for building attention and processing skills, which he suspects are at the heart of many post–COVID-19 patients' impairments. Spudich, too, says she would welcome a web- or app-based attention-training game to help patients take charge of enduring COVID-19 symptoms against which they feel powerless. "Frankly, I think those things will make a difference on outcomes, even if they're not proven in a clinical trial," she says. "The hopelessness people feel in this situation is really palpable."
Markdown	[Skip to main content](https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments#main-content-focus) - [news](https://www.science.org/news) - [careers](https://www.science.org/careers) - [commentary](https://www.science.org/commentary) - [Journals](https://www.science.org/journals) [![](https://www.science.org/pb-assets/images/styleguide/logo-dark-1672180581427.svg) ![Science](https://www.science.org/pb-assets/images/styleguide/logo-1672180580750.svg)](https://www.science.org/) - [Log in](https://www.science.org/action/ssostart?redirectUri=%2Fcontent%2Farticle%2Fcovid-19-brain-fog-inspires-search-causes-and-treatments) - [Become A Member](https://promo.aaas.org/science/join/?CTC=SMHPJN) [![journal-menu-img](https://www.science.org/cms/asset/ce70d779-babe-474b-bf8a-dac5fac45e2f/science.2026.391.issue-6782.cover.gif)science](https://www.science.org/journal/science "Science") [![journal-menu-img](https://www.science.org/cms/asset/27e14422-4415-4f18-89c7-a9c84ea35cec/sciadv.2026.12.issue-3.cover.gif)science advances](https://www.science.org/journal/sciadv "Science") [![journal-menu-img](https://www.science.org/cms/asset/cba30519-96c0-495c-9947-985829095f0c/sciimmunol.2026.11.issue-115.cover.gif)science immunology](https://www.science.org/journal/sciimmunol "Science") [![journal-menu-img](https://www.science.org/cms/asset/0a672c1f-b2bb-4a14-b414-475b8cb8174f/scirobotics.2026.11.issue-110.cover.gif)science robotics](https://www.science.org/journal/scirobotics "Science") [![journal-menu-img](https://www.science.org/cms/asset/e403a4d2-c06d-4053-84c2-488e56fe9e60/signaling.2026.19.issue-920.cover.gif)science signaling](https://www.science.org/journal/signaling "Science") [![journal-menu-img](https://www.science.org/cms/asset/dfc1c721-f0e5-40e8-90c4-d7bb696650c2/stm.2026.18.issue-832.cover.gif)science translational medicine](https://www.science.org/journal/stm "Science") [![journal-menu-img](https://www.science.org/pb-assets/images/styleguide/spj-cover-1695403298717.png)science partner journals](https://spj.science.org/ "Science Partner Journals") Searching: Anywhere [Anywhere](https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments#quick-search-form-9ea9b667-c3ce-40d1-870b-f7e001bbac01-0)[Science](https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments#quick-search-form-9ea9b667-c3ce-40d1-870b-f7e001bbac01-1)[Science Advances](https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments#quick-search-form-9ea9b667-c3ce-40d1-870b-f7e001bbac01-2)[Science Immunology](https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments#quick-search-form-9ea9b667-c3ce-40d1-870b-f7e001bbac01-3)[Science Robotics](https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments#quick-search-form-9ea9b667-c3ce-40d1-870b-f7e001bbac01-4)[Science Signaling](https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments#quick-search-form-9ea9b667-c3ce-40d1-870b-f7e001bbac01-5)[Science Translational Medicine](https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments#quick-search-form-9ea9b667-c3ce-40d1-870b-f7e001bbac01-6) [Advanced Search](https://www.science.org/search/advanced) Search ###### Trending Terms: - [cancer](https://www.science.org/action/doSearch?AllField=cancer) - [climate](https://www.science.org/action/doSearch?AllField=climate) - [artificial intelligence](https://www.science.org/action/doSearch?AllField=artificial%20intelligence) - [postdoc](https://www.science.org/action/doSearch?AllField=postdoc) - [aging](https://www.science.org/action/doSearch?AllField=aging) - [Log In](https://www.science.org/action/ssostart?redirectUri=/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments) - [Become A Member](https://promo.aaas.org/science/join/?CTC=SMLDJN) - [Donate](https://www.science.org/news/donate?intcmp=sitemenu-donate&utm_id=recB0g01G48yiGSBD) [science.org](https://www.science.org/) - [news](https://www.science.org/news) - [News Home](https://www.science.org/news) - [All News](https://www.science.org/news/all-news) - [ScienceInsider](https://www.science.org/news/scienceinsider) - [News Features](https://www.science.org/news/features) - [careers](https://www.science.org/careers) - [commentary](https://www.science.org/commentary) - [Journals](https://www.science.org/journals) - [science](https://www.science.org/journal/science) - [science advances](https://www.science.org/journal/sciadv) - [science immunology](https://www.science.org/journal/sciimmunol) - [science robotics](https://www.science.org/journal/scirobotics) - [science signaling](https://www.science.org/journal/signaling) - [science translational medicine](https://www.science.org/journal/stm) - [science partner journals](https://spj.science.org/) - [Custom publishing](https://www.science.org/custom-publishing) - [prizes and awards](https://www.science.org/content/page/prizes-and-awards) - [newsletters](https://www.science.org/topic/article-type/scienceadviser?intcmp=menu-adviserfeed&utm_id=recI11u4srAIiGNLZ) - [collections](https://www.science.org/collections) - [videos](https://www.science.org/videos) - [podcasts](https://www.science.org/podcasts) - [blogs](https://www.science.org/blogs) - [visualizations](https://www.science.org/visualizations) - [authors & reviewers](https://www.science.org/content/page/contributing-science-family-journals) - [librarians](https://www.science.org/content/page/librarian-portal) - [advertisers](https://advertising.sciencemag.org/) - [about](https://www.science.org/content/page/aboutus) - [help](https://www.science.org/content/page/help) ![AAAS Science Logo](https://www.science.org/pb-assets/images/styleguide/logo-1672180580750.svg) - [Terms of Service](https://www.science.org/content/page/terms-service) - [Privacy Policy](https://www.science.org/content/page/privacy-policy) - [Accessibility](https://www.science.org/content/page/accessibility) - [News Home](https://www.science.org/news) - [All News](https://www.science.org/news/all-news) - [ScienceInsider](https://www.science.org/news/scienceinsider) - [News Features](https://www.science.org/news/features) - [Donate](https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments#donation-blackbud-modal) [GET OUR E-ALERTS](https://www.science.org/action/showPreferences?menuTab=Alerts) Main content starts here [Home](https://www.science.org/)[News](https://www.science.org/news)[ScienceInsider](https://www.science.org/news/scienceinsider)COVID-19 ‘brain fog' inspires search for causes and treatments [Back To ScienceInsider](https://www.science.org/news/scienceinsider) - [ScienceInsider](https://www.science.org/news/scienceinsider "ScienceInsider") - [Health](https://www.science.org/topic/category/health) # COVID-19 ‘brain fog' inspires search for causes and treatments ## Disentangling the roots of survivors’ cognitive deficits is no easy task - 27 Apr 2021 - By[Kelly Servick](https://www.science.org/content/author/kelly-servick "Kelly Servick") ![conceptual illustration of a viruses and clouds in the air around a woman wearing a mask](https://www.science.org/cms/asset/17f16225-aa68-405f-a9d0-f800ea155da9/main_brainfog_1280p.jpg) Ponomariova\_Maria/iStock Share: - [Facebook](https://www.science.org/#facebook "Facebook") - [Share on X](https://www.science.org/#twitter "Share on X") - [Linked In](https://www.science.org/#linkedin "Linked In") - [Reddit](https://www.science.org/#reddit "Reddit") - [Wechat](https://www.science.org/#wechat "Wechat") - [Whatsapp](https://www.science.org/#whatsapp "Whatsapp") - [Email](https://www.science.org/#email "Email") Science's COVID-19 reporting is supported by the Heising-Simons Foundation. Since she fell ill with COVID-19 around Thanksgiving, Pamela Furr has been waiting for her old self to return. A radio news anchor in Tennessee for more than 10 years, she now sometimes finds herself stuck midsentence grasping for simple words; she is prone to forget events and conversations if she doesn't write them down. "I'm not the same person that I was before COVID," she says. "I kind of miss me." The true prevalence of cognitive problems in COVID-19 survivors is elusive, and the underlying causes of lingering symptoms [are the subject of ongoing studies](https://www.sciencemag.org/news/2021/04/how-scientists-are-teasing-apart-biology-long-covid). But it's now clear that trouble thinking, concentrating, and remembering can be among the most debilitating "long-haul" symptoms and can persist for months. As more and more people seek help to overcome their brain fog at clinics set up for post–COVID-19 care, researchers and physicians are turning to treatments developed for stroke and traumatic brain injuries. And a few are setting out to test cognitive training video games they hope will expand the reach of therapy. "Even if it's a fairly small percentage \[of survivors\] who report cognitive problems, the number of overall people in that category … represents a tremendous problem," says James Jackson, a clinical psychologist at the Vanderbilt University School of Medicine's ICU Recovery Center, where Furr will participate in a support group for COVID-19 long haulers. Cognitive impairment is common after serious illness. It's among the symptoms of a condition called [post–intensive care syndrome](https://www.sciencemag.org/news/2020/04/survivors-severe-covid-19-beating-virus-just-beginning) that can follow the isolation, immobility, and sedation of a hospital stay. And severe COVID-19 can itself damage the brain during its acute phase. SARS-CoV-2 may rarely invade brain tissue directly; most neurological damage is thought to stem from the indirect effects of infection, such as inflammation, stroke, and lack of oxygen. "I'm not sure that what we're seeing post-COVID is different" from impairments after other serious respiratory illnesses, says Faith Gunning, a neuropsychologist at Weill Cornell Medicine (WCM). She and colleagues reported in February that of 57 recovering COVID-19 patients referred for neuropsychological evaluation before hospital discharge, [81% had cognitive impairment](https://www.nature.com/articles/s41386-021-00978-8). Most experienced problems with attention and executive function, which includes skills like planning, organization, and multitasking. #### Advertisement And such symptoms aren't limited to people who wound up hospitalized. The majority of people visiting post–COVID-19 outpatient clinics had a relatively mild acute phase of illness, says Igor Koralnik, a neurologist at Northwestern University's Feinberg School of Medicine. He oversees the Neuro COVID-19 Clinic at Northwestern Memorial Hospital, which has seen more than 400 patients since it opened in May 2020. Among the first 100 patients with confirmed COVID-19 infections whose symptoms lasted at least 6 weeks, [81 experienced "brain fog,"](https://onlinelibrary.wiley.com/doi/10.1002/acn3.51350) the most common neurologic symptom, Koralnik's team reported last month in the Annals of Clinical and Translational Neurology. After brain injury, cognitive rehab typically involves testing to identify cognitive weaknesses and training to help patients navigate daily life. Often, the focus is on compensating for deficits, not eliminating them outright. Jackson's team at Vanderbilt recommends a rehabilitation program called goal management training, originally developed to manage impairments after stroke, traumatic brain injury, or age-related decline. It trains patients in "metacognitive skills" such as observing their own thought processes, identifying situations where they're prone to make cognitive errors, and reflecting on how to approach a new task. It can be "a game changer" for patients, Jackson says. He expects such training to benefit people with post–COVID-19 impairments—but only if their primary care physicians refer them as they would people who had a stroke or traumatic injury. For now, that happens rarely, he says. ![quotation mark](https://www.science.org/pb-assets/images/styleguide/quotation-mark-1746033675637.svg) Any time you're developing a treatment, you need to understand the mechanism. But we can't afford to wait. We need to do something now. - Ana-Maria Vranceanu, Harvard Medical School Complicating matters for doctors is that the nature of the injuries is often far from clear. "We don't really know what happened to them," says Serena Spudich, an infectious disease neurologist at the Yale School of Medicine. When cognitive dysfunction appears after mild COVID-19, it raises the possibility that an immune response that was protective in the acute phase has become overactive and triggered continuing inflammation, she says. Spudich leads a study using brain imaging along with analyses of spinal fluid and other biological samples to look for signs of inflammation and other abnormalities in patients with persistent post–COVID-19 neurological symptoms. There are other possible explanations for cognitive impairments. "Things like sleep and exhaustion, pain and stress and depression—all of these nonneurological issues also play a role in our cognitive functioning," says Renee Madathil, a rehabilitation neuropsychologist at the University of Rochester Medical Center. Cognitive impairments rooted in depression or stress aren't any less "real" than those caused by direct injury to the brain, Madathil and others stress. But different causes may call for different therapies. "Any time you're developing a treatment, you need to understand the mechanism," says Ana-Maria Vranceanu, a clinical health psychologist at Harvard Medical School. "But we can't afford to wait," she adds. "We need to do something now." In prepandemic studies of intensive care unit (ICU) survivors, her team found that elevated emotional distress spelled a slower recovery. Her team developed a training program to help ICU survivors and their families manage distress, anxiety, and depression, which she aims to adapt for COVID-19 recovery. To help people who neither live near rehabilitation centers nor have access to specialists, a few researchers are exploring a newer category of potential treatments: cognitive training through video games played at home. In response to what he calls "a tsunami of patients with Long COVID," Radboud University Medical Center professor of surgery Harry van Goor, with Radboud physical therapy researcher Bart Staal, is testing a virtual reality platform and a set of games that involve physical activity, cognitive skills, and mindfulness. A pilot study in 48 people recovering from COVID-19 suggests the puzzlelike cognitive games were highly motivating, the researchers say; they next hope to launch a controlled trial of the approach versus traditional rehab. Meanwhile, Jackson's team at Vanderbilt and Gunning's at WCM are gearing up to test a "digital treatment" developed by Akili Interactive, which last year became the first company to win approval from the U.S. Food and Drug Administration for a video game as a prescription therapy. The technology, so far approved for attention deficit hyperactivity disorder (ADHD), "is not just a blunderbuss approach" to treat any condition that involves cognitive dysfunction, says Anil Jina, Akili's chief medical officer. Instead, it's designed to improve attention—for example, by having players multitask to collect items in the game while avoiding obstacles. A study of more than 300 children with ADHD published last year showed that those who played the game [showed greater improvements](https://www.thelancet.com/journals/landig/article/PIIS2589-7500$20$30017-0/fulltext) in computerized attention tests and on parent and clinician assessments than those who used an educational video game. ![A racing video game set underwater](https://www.science.org/cms/asset/58daad4d-f7b5-4c49-9d61-2c8b4f6420b4/secondary_endeavor_soup_1280p.jpg) A video game developed by Akili Interactive challenges attention with a series of targets and obstacles. Akili Interactive Gunning's study, set to launch next month, aims to include 100 participants who have lingering cognitive deficits after COVID-19; Jackson's group expects to include more than 50 people with such symptoms. In both studies, half the participants will be assigned to 6 weeks of at-home play. Half will serve as controls but will have access to the game after the assessment is complete. The brain-training industry [has a checkered reputation](https://science.sciencemag.org/content/351/6270/212.full) when it comes to science. In 2016, Lumos Labs, the company behind the popular program Lumosity, agreed to pay the Federal Trade Commission \$2 million to settle false advertising charges after promoting its games as a way to stave off Alzheimer's disease and other conditions without adequate evidence. In studies of cognitive decline accompanying aging, puzzles and cognitive games haven't proved as effective as physical activity and an active social life, Vranceanu notes. "If you're doing Sudoku, you're getting good at Sudoku," she says, "but that doesn't necessarily translate to you getting better at not misplacing your keys." And in rehabilitation, the transfer of skills from games and exercises in the clinic to everyday life "does not occur easily," cautions Edward Taub, a behavioral psychologist at the University of Alabama, Birmingham (UAB). He and UAB rehabilitation psychologist Gitendra Uswatte are recruiting post–COVID-19 patients with cognitive impairment to a small pilot study of "constraint-induced cognitive therapy," based on techniques Taub and colleagues first developed to help patients after strokes. It includes a video game that challenges a player's processing speed, as well as training on daily activities, such as making a shopping list or organizing medications, and monitored homework to help patients apply skills from the game to their lives. Jackson knows brain training has its limits. But he argues that emerging evidence supports its value for building attention and processing skills, which he suspects are at the heart of many post–COVID-19 patients' impairments. Spudich, too, says she would welcome a web- or app-based attention-training game to help patients take charge of enduring COVID-19 symptoms against which they feel powerless. "Frankly, I think those things will make a difference on outcomes, even if they're not proven in a clinical trial," she says. "The hopelessness people feel in this situation is really palpable." *** doi: 10.1126/science.abj2105 #### Relevant tags: [Health](https://www.science.org/topic/category/health "Health") [Coronavirus](https://www.science.org/topic/tags/coronavirus "Coronavirus") ## About the author ![Kelly Servick](https://www.science.org/cms/asset/a550405f-1c4c-40af-8a6e-6a7c181ed3da/kellyservick-headshot.jpg) #### [Kelly Servick](https://www.science.org/content/author/kelly-servick) [mail](mailto:kservick@aaas.org "mail")[Share on X](https://www.twitter.com/@kellyservick "Share on X") ##### Author Kelly Servick is a staff writer at Science. [View more](https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments) ## More from news [![An illustration of a microscope examining a row of papers](https://www.science.org/cms/asset/fa01746c-9f8e-44ff-b523-b5dc1d1d91ad/_20260116__on_scrutinzingpapers.jpg)](https://www.science.org/content/article/some-guest-editors-pack-special-issues-their-own-articles "Some guest editors pack special issues with their own articles") 16 Jan 2026 [Some guest editors pack special issues with their own articles](https://www.science.org/content/article/some-guest-editors-pack-special-issues-their-own-articles "Some guest editors pack special issues with their own articles") By - Jeffrey Brainard [![Purdue University campus](https://www.science.org/cms/asset/5ad91c48-8225-4203-af3f-b2601291ef40/_20260114_on_purdue.jpg)](https://www.science.org/content/article/purdue-blocks-admission-many-chinese-grad-students-unwritten-policy "Purdue blocks admission of many Chinese grad students in unwritten policy") 16 Jan 2026 [Purdue blocks admission of many Chinese grad students in unwritten policy](https://www.science.org/content/article/purdue-blocks-admission-many-chinese-grad-students-unwritten-policy "Purdue blocks admission of many Chinese grad students in unwritten policy") By - Jeffrey Mervis [![Ring nebula](https://www.science.org/cms/asset/523444aa-2275-43ab-ba90-3e3ceee5b93c/_20260115_on_ring_nebula_lede.jpg)](https://www.science.org/content/article/did-vaporized-alien-planet-leave-behind-strange-iron-bar "Did a vaporized alien planet leave behind a strange iron ‘bar’?") 15 Jan 2026 [Did a vaporized alien planet leave behind a strange iron ‘bar’?](https://www.science.org/content/article/did-vaporized-alien-planet-leave-behind-strange-iron-bar "Did a vaporized alien planet leave behind a strange iron ‘bar’?") By - Jenna Ahart [View more](https://www.science.org/news/all-news) Got a tip for Science's news department? [Connect](https://www.science.org/content/page/got-tip) ### Sign up for ScienceAdviser Get Science’s award-winning newsletter with the latest news, commentary, and research, free to your inbox daily. [Subscribe](https://www.science.org/content/page/scienceadviser?intcmp=rrail-adviser&utm_id=recFUzjFNRznSEEDd) ## ScienceInsider [![An illustration of a microscope examining a row of papers](https://www.science.org/cms/asset/fa01746c-9f8e-44ff-b523-b5dc1d1d91ad/_20260116__on_scrutinzingpapers.jpg)](https://www.science.org/content/article/some-guest-editors-pack-special-issues-their-own-articles "Some guest editors pack special issues with their own articles") 16 Jan 2026 By - Jeffrey Brainard [Some guest editors pack special issues with their own articles](https://www.science.org/content/article/some-guest-editors-pack-special-issues-their-own-articles "Some guest editors pack special issues with their own articles") [![Purdue University campus](https://www.science.org/cms/asset/5ad91c48-8225-4203-af3f-b2601291ef40/_20260114_on_purdue.jpg)](https://www.science.org/content/article/purdue-blocks-admission-many-chinese-grad-students-unwritten-policy "Purdue blocks admission of many Chinese grad students in unwritten policy") 16 Jan 2026 By - Jeffrey Mervis [Purdue blocks admission of many Chinese grad students in unwritten policy](https://www.science.org/content/article/purdue-blocks-admission-many-chinese-grad-students-unwritten-policy "Purdue blocks admission of many Chinese grad students in unwritten policy") [![Pampas Verdes](https://www.science.org/cms/asset/710419b8-15d4-4827-9cb0-1eb17d9391a6/_20260114_on_peru_mining_lede.jpg)](https://www.science.org/content/article/illegal-miners-have-forced-peru-s-oldest-environmental-research-station-suspend-work "Illegal miners have forced Peru’s oldest environmental research station to suspend work") 15 Jan 2026 By - Kata Karáth [Illegal miners have forced Peru’s oldest environmental research station to suspend work](https://www.science.org/content/article/illegal-miners-have-forced-peru-s-oldest-environmental-research-station-suspend-work "Illegal miners have forced Peru’s oldest environmental research station to suspend work") [![Bethany Hickey holds her 6 month old son, Alexander while he receives a Prevnar Pneumococcal Meningitis vaccine](https://www.science.org/cms/asset/dd3cf634-637e-4915-a3d4-6f9644184e50/_20250108_on_trump_vaccines.jpg)](https://www.science.org/content/article/trump-administration-says-some-approved-childhood-vaccines-need-better-studies "The Trump administration says some approved childhood vaccines need better studies. Scientists disagree") 8 Jan 2026 By - Jon Cohen [The Trump administration says some approved childhood vaccines need better studies. Scientists disagree](https://www.science.org/content/article/trump-administration-says-some-approved-childhood-vaccines-need-better-studies "The Trump administration says some approved childhood vaccines need better studies. Scientists disagree") [View more](https://www.science.org/news/scienceinsider) ## Sifter [![fMRI image of preteen brain](https://www.science.org/cms/asset/6f3fa20c-bfd8-4a2b-8660-95871cc9a84f/_sf_brainmapping.jpg)](https://www.science.org/content/article/flaw-brain-mapping-technique-may-undercut-neuroscience-findings "Flaw in brain-mapping technique may undercut neuroscience findings") 16 Jan 2026 By - Catherine Offord [Flaw in brain-mapping technique may undercut neuroscience findings](https://www.science.org/content/article/flaw-brain-mapping-technique-may-undercut-neuroscience-findings "Flaw in brain-mapping technique may undercut neuroscience findings") [![Ground rosettes](https://www.science.org/cms/asset/09c8cf4d-d2a8-4e48-9d8c-1353bc15a850/arabidopsis_thaliana_sifter.jpg)](https://www.science.org/content/article/plants-cope-stress-touching-each-other "Plants cope with stress by touching each other") 15 Jan 2026 By - Claudia Steiner [Plants cope with stress by touching each other](https://www.science.org/content/article/plants-cope-stress-touching-each-other "Plants cope with stress by touching each other") [![A plastic bag for biohazard waste](https://www.science.org/cms/asset/22c8c5d9-6e09-432f-a5fb-0e6abf5558b9/_sf_labsafety.jpg)](https://www.science.org/content/article/leading-ai-models-miss-dangerous-lab-risks "Leading AI models miss dangerous lab risks") 15 Jan 2026 By - Celina Zhao [Leading AI models miss dangerous lab risks](https://www.science.org/content/article/leading-ai-models-miss-dangerous-lab-risks "Leading AI models miss dangerous lab risks") [![Galápagos sea lion](https://www.science.org/cms/asset/043732cc-6747-47a2-b90f-19c2ac923a19/_sf_sealion.jpg)](https://www.science.org/content/article/some-nursing-sea-lions-it-s-never-too-old-mom "For some nursing sea lions, it’s never too old for mom") 13 Jan 2026 By - Alessio Cozzolino [For some nursing sea lions, it’s never too old for mom](https://www.science.org/content/article/some-nursing-sea-lions-it-s-never-too-old-mom "For some nursing sea lions, it’s never too old for mom") [View more](https://www.science.org/news/sifter) ## Recommended[Close](https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments) In Depth March 2020 [Race to find COVID-19 treatments accelerates](https://www.science.org/doi/full/10.1126/science.367.6485.1412 "Race to find COVID-19 treatments accelerates") Editorial May 2020 [COVID-19 amidst Ebola's retreat](https://www.science.org/doi/full/10.1126/science.abc4859 "COVID-19 amidst Ebola's retreat") Editorial June 2020 [COVID-19 and flu, a perfect storm](https://www.science.org/doi/full/10.1126/science.abd2220 "COVID-19 and flu, a perfect storm") Editorial July 2020 [COVID-19 and the next influenza season](https://www.science.org/doi/full/10.1126/sciadv.abd0086 "COVID-19 and the next influenza season") SPONSORED [webinar](https://www.science.org/custom-publishing/webinars "webinars") Science and Life 18 Dec 2025 [Building a global community for rare disease: Accelerating treatments, access, and collaboration](https://www.science.org/content/webinar/building-global-community-rare-disease-accelerating-treatments-access-and-collaboration "Building a global community for rare disease: Accelerating treatments, access, and collaboration") ![](https://www.science.org/specs/products/aaas/releasedAssets/images/logo-dark-5054d3662e2bdb9b57c1aa182d7a711e.svg) × ##### Support nonprofit science journalism Amid the unprecedented upheaval in U.S. science, hard-hitting, trustworthy reporting has never been more important. As part of the AAAS mission, Science has built a global award-winning network of reporters and editors that independently cover the most important developments in research and policy. Your tax-deductible contribution plays a critical role in sustaining this effort. If, at any time, you would like to stop or make changes to your monthly gift, please contact the Philanthropy Office at [philanthropy@aaas.org](mailto:philanthropy@aaas.org) or 202-326-6636. [Charitable Disclosures](https://www.aaas.org/governance/disclosures) Loading... [Skip slideshow](https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments#afterSlideshow-j3n) ###### [Follow Us](https://www.science.org/content/page/science-family-journals-social-media) - [Get our newsletter](https://www.science.org/content/page/scienceadviser?intcmp=ftr-adviser&utm_id=recdExfxt1yeSJxzi) - [NEWS](https://www.science.org/news) - [All News](https://www.science.org/news/all-news) - [ScienceInsider](https://www.science.org/news/scienceinsider) - [News Features](https://www.science.org/news/features) - [Subscribe to News from Science](https://www.science.org/content/page/news-science-subscriptions?intcmp=footer-subscribetonews&utm_id=recziGpGO7jMVeez2) - [News from Science FAQ](https://www.science.org/content/page/news-subscriber-faqs) - [About News from Science](https://www.science.org/content/page/about-news-science) - [Donate to News](https://www.science.org/news/donate?intcmp=footer-donate&utm_id=recVQVKKRRLdidlGT) - [CAREERS](https://www.science.org/careers) - [Careers Articles](https://www.science.org/topic/article-type/careers-editorial) - [Find Jobs](https://jobs.sciencecareers.org/) - [Employer Hubs](https://www.science.org/careers/employers) - [COMMENTARY](https://www.science.org/commentary) - [Opinion](https://www.science.org/commentary/opinion) - [Analysis](https://www.science.org/commentary/analysis) - [Blogs](https://www.science.org/blogs) - [JOURNALS](https://www.science.org/journals) - [Science](https://www.science.org/journal/science) - [Science Advances](https://www.science.org/journal/sciadv) - [Science Immunology](https://www.science.org/journal/sciimmunol) - [Science Robotics](https://www.science.org/journal/scirobotics) - [Science Signaling](https://www.science.org/journal/signaling) - [Science Translational Medicine](https://www.science.org/journal/stm) - [Science Partner Journals](https://spj.sciencemag.org/) - [AUTHORS & REVIEWERS](https://www.science.org/content/page/contributing-science-family-journals) - [Information for Authors](https://www.science.org/content/page/contributing-science-family-journals) - [Information for Reviewers](https://www.science.org/content/page/peer-review-science-publications) - [LIBRARIANS](https://www.science.org/content/page/librarian-portal) - [Manage Your Institutional Subscription](https://www.science.org/action/institutionAccessEntitlements) - [Library Admin Portal](https://www.science.org/content/page/librarian-portal) - [Request a Quote](https://scienceaaas.org/request) - [Librarian FAQs](https://www.science.org/content/page/librarian-portal-frequently-asked-questions) - [ADVERTISERS](https://advertising.sciencemag.org/) - [Advertising Kits](https://advertising.sciencemag.org/) - [Custom Publishing Info](https://www.science.org/custom-publishing) - [Post a Job](https://employers.sciencecareers.org/) - [RELATED SITES](https://www.science.org/content/page/related-sites) - [AAAS.org](https://www.aaas.org/) - [AAAS Communities](https://members.aaas.org/home) - [EurekAlert\!](https://www.eurekalert.org/) - [Science in the Classroom](https://www.scienceintheclassroom.org/) - [ABOUT US](https://www.science.org/content/page/aboutus) - [Leadership](https://www.science.org/content/page/leadership-and-management) - [Work at AAAS](https://www.aaas.org/careers/workataaas) - [Prizes and Awards](https://www.science.org/content/page/prizes-and-awards) - [HELP](https://www.science.org/content/page/help) - [FAQs](https://www.science.org/content/page/faqs) - [Access and Subscriptions](https://www.science.org/content/page/access-and-subscriptions) - [Order a Single Issue](https://backissues.science.org/) - [Reprints and Permissions](https://www.science.org/content/page/reprints-and-permissions) - [TOC Alerts and RSS Feeds](https://www.science.org/content/page/email-alerts-and-rss-feeds) - [Contact Us](https://www.science.org/content/page/contact-us) ###### [Follow Us](https://www.science.org/content/page/science-family-journals-social-media) [Get our newsletter](https://www.science.org/content/page/scienceadviser?intcmp=ftr-adviser&utm_id=recdExfxt1yeSJxzi) [![AAAS logo](https://www.science.org/pb-assets/images/styleguide/aaas-logo-1672180581667.svg)](https://www.aaas.org/ "Visit the AAAS homepage") © 2026 American Association for the Advancement of Science. All rights reserved. AAAS is a partner of HINARI, AGORA, OARE, CHORUS, CLOCKSS, CrossRef and COUNTER. back to top - [Terms of Service](https://www.science.org/content/page/terms-service "Terms of Service") - [Privacy Policy](https://www.science.org/content/page/privacy-policy "Privacy Policy") - [Cookie Preferences](https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments#cookie-preferences "Cookie Preferences") - [Accessibility](https://www.science.org/content/page/accessibility "Accessibility") ![news-white-logo](https://www.science.org/pb-assets/images/popup-logos/news-white-logo-1712047935.png) × [![AAAS Annual Meeting](https://www.science.org/pb-assets/images/logos/AAAS-AM26-LogoBlue-1768408324583.png)](https://meetings.aaas.org/attend-phx/registration/?utm_medium=display&utm_source=membership-website&utm_campaign=am2026&utm_content=reg&utm_id=recOPRLd3NNbUXuLe) Join us in Phoenix 12–14 February to define where science goes next. Register by 22 January for lowest rate. [Register](https://meetings.aaas.org/attend-phx/registration/?utm_medium=display&utm_source=membership-website&utm_campaign=am2026&utm_content=reg&utm_id=recOPRLd3NNbUXuLe)[Not Now](https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments) ✓ Thanks for sharing\! [AddToAny](https://www.addtoany.com/ "Share Buttons") [More…](https://www.science.org/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments#addtoany "Show all")
Readable Markdown	null
Shard	23 (laksa)
Root Hash	18350995765413815023
Unparsed URL	org,science!www,/content/article/covid-19-brain-fog-inspires-search-causes-and-treatments s443